Literature DB >> 21531246

Effects of the use of hypnotics on cognition.

Annemiek Vermeeren1, Anton M L Coenen.   

Abstract

Hypnotic drugs are intended to induce sedation and promote sleep. As a result, they have deteriorating effects on cognitive performance following intake. Most hypnotics are benzodiazepine receptor agonists which can have effects on memory in addition to their sedative effects. Other sedating drugs, such as histamine H1 antagonists or melatonin agonists, may have less effect on memory and learning. Hypnotics with other mechanisms of action are currently being investigated for efficacy and safety. For patients using hypnotic drugs, the effects on cognition are relevant to the extent that a drug dose affects daytime performance. Use of benzodiazepine hypnotics is associated with increased risk of car accidents and falling. Therefore, most hypnotics are studied to determine whether they produce residual sedation and impairing effects on performance the morning after bedtime use. Experimental studies using a standardized driving test clearly show that some drugs and doses produce severe residual effects, whereas others seem to have no or only minor impairing effects on next-day performance. No hypnotic has been found yet to improve daytime performance. Studies on long-term use of benzodiazepine hypnotics suggest that effects on daytime performance may diminish over time due to tolerance. However, there are also studies showing that performance may improve after discontinuation of chronic benzodiazepine use, which suggests that tolerance may not be complete.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531246     DOI: 10.1016/B978-0-444-53817-8.00005-0

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  23 in total

1.  A Case of Transient Global Amnesia: A Review and How It May Shed Further Insight into the Neurobiology of Delusions.

Authors:  David R Spiegel; Aidan L Mccroskey; Branden A Deyerle
Journal:  Innov Clin Neurosci       Date:  2016-04-01

2.  Psychological treatment of hypnotic-dependent insomnia in a primarily older adult sample.

Authors:  Kenneth L Lichstein; Sidney D Nau; Nancy M Wilson; R Neal Aguillard; Kristin W Lester; Andrew J Bush; Christina S McCrae
Journal:  Behav Res Ther       Date:  2013-09-26

Review 3.  Sleep, cognition, and normal aging: integrating a half century of multidisciplinary research.

Authors:  Michael K Scullin; Donald L Bliwise
Journal:  Perspect Psychol Sci       Date:  2015-01

4.  Total Sleep Time Interacts With Age to Predict Cognitive Performance Among Adults.

Authors:  Brian S Mohlenhoff; Philip S Insel; R Scott Mackin; Thomas C Neylan; Derek Flenniken; Rachel Nosheny; Anne Richards; Paul Maruff; Michael W Weiner
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

5.  A randomized, double-blind, single-dose, placebo-controlled, multicenter, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.

Authors:  Russell P Rosenberg; Steven G Hull; D Alan Lankford; David W Mayleben; David J Seiden; Sandy A Furey; Shyamalie Jayawardena; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

6.  PTSD symptom presentation among people with alcohol and drug use disorders: Comparisons by substance of abuse.

Authors:  Emily R Dworkin; Sonya Wanklyn; Paul R Stasiewicz; Scott F Coffey
Journal:  Addict Behav       Date:  2017-08-18       Impact factor: 3.913

Review 7.  Treatment of Sleep Disorders in Dementia.

Authors:  Sharon Ooms; Yo-El Ju
Journal:  Curr Treat Options Neurol       Date:  2016-09       Impact factor: 3.598

8.  Effects of pregabalin in patients with hypnotic-dependent insomnia.

Authors:  Youg Won Cho; Mei Ling Song
Journal:  J Clin Sleep Med       Date:  2014-05-15       Impact factor: 4.062

9.  Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys.

Authors:  Pamela L Tannenbaum; Spencer J Tye; Joanne Stevens; Anthony L Gotter; Steven V Fox; Alan T Savitz; Paul J Coleman; Jason M Uslaner; Scott D Kuduk; Richard Hargreaves; Christopher J Winrow; John J Renger
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

Review 10.  Advancing study of cognitive impairments for antipsychotic-naïve psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology.

Authors:  Lawrence H Yang; Bernalyn Ruiz; Amar D Mandavia; Margaux M Grivel; Liang Y Wong; Michael R Phillips; Matcheri S Keshavan; Huijun Li; Jeffrey A Lieberman; Ezra Susser; Larry J Seidman; William S Stone
Journal:  Schizophr Res       Date:  2020-04-05       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.